S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

clinical trial

S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT00096031

P6099clinical trial phasephase II clinical trialQ42824440
P17countryUnited States of AmericaQ30
P582end time2008-01-01
P4135maximum age120
P2899minimum age18
P1132number of participants63
P6153research siteHackley Hospital Emergency heliportQ61673570
University of MichiganQ230492
Fred Hutchinson Cancer Research CenterQ1452369
Denver Health Medical CenterQ3023367
Barbara Ann Karmanos Cancer InstituteQ4858714
Munson Medical CenterQ6936903
Piedmont HospitalQ7191520
Swedish Medical CenterQ7654755
Wilford Hall Medical CenterQ8001708
P580start time2004-10-01
P8363study typeinterventional studyQ78089383
P1476titleCetuximab As Second Line Therapy In Patients With Metastatic Esophageal Cancer - Phase II

Search more.